Mersana Therapeutics, Inc. Stockholders' Equity, Period Increase (Decrease)
Mersana Therapeutics, Inc. reported Stockholders' Equity, Period Increase (Decrease) of -$40.14 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Shareholders' Equity
us-gaap:StockholdersEquityPeriodIncreaseDecrease · last filed 2018-11-13
- Mersana Therapeutics, Inc. stockholders' equity, period increase (decrease) for the quarter ending 2018-09-30 was -$15.84M.
- Mersana Therapeutics, Inc. stockholders' equity, period increase (decrease) for the quarter ending 2018-06-30 was -$10.85M.
- Mersana Therapeutics, Inc. stockholders' equity, period increase (decrease) for the quarter ending 2018-03-31 was -$13.45M.
| Period end | Stockholders' Equity, Period Increase (Decrease) 3 month | Stockholders' Equity, Period Increase (Decrease) 6 month | Stockholders' Equity, Period Increase (Decrease) 9 month | Stockholders' Equity, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$15.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$26.69M derived: sum of 2 quarters · filed 2018-11-13 | -$40.14M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$10.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$24.30M 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | -$13.45M 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | $125.61M 10-Q · filed 2018-11-13 |